Workflow
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Core Insights - Klotho Neurosciences, Inc. is set to present at Biotech Showcase 2025, focusing on its innovative therapies for neurodegenerative diseases [1][2] - The company is developing cell and gene therapies targeting ALS, Alzheimer's, and Parkinson's disease, utilizing the Klotho anti-aging gene [2][3] - Klotho Neurosciences has secured exclusive worldwide licenses for its therapeutic approach, covering patents in the USA, Europe, and China [2] Company Overview - Klotho Neurosciences, Inc. specializes in biopharmaceuticals, particularly in cell and gene therapies derived from the Klotho gene [3] - The company’s portfolio includes DNA and RNA therapeutics, genomics-based diagnostics, and clinical-stage programs targeting cancer and autoimmune diseases [3] - Management comprises experienced professionals in biopharmaceutical product development and commercialization [3] Presentation Details - The presentation is scheduled for January 14, 2025, at 3:00 PM PT during J.P. Morgan Healthcare Week [1][2] - Dr. Joseph Sinkule, the Founder, CEO, and Chairman, will discuss the company's advancements and the role of the Klotho gene in treating neurodegenerative diseases [2] - The event is expected to attract over 3,200 healthcare professionals and more than 1,200 investors [1]